The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The U.S. Digital Therapeutics Market encompasses software-driven solutions designed to prevent, manage, and treat medical conditions and diseases through evidence-based, clinically validated digital ...

"By combining internal, pre-clinical experimental data, with real-world data from Tempus on its AI-powered platform, we can profoundly deepen our understanding of cancer biology and accelerate our ...

Tech companies are focusing on AI products over research, say industry experts, who are sounding the alarm about safety.

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...